Logo image of HOOK

HOOKIPA PHARMA INC (HOOK) Stock Fundamental Analysis

NASDAQ:HOOK - Nasdaq - US43906K2096 - Common Stock - Currency: USD

1.28  -0.06 (-4.48%)

After market: 1.26 -0.02 (-1.56%)

Fundamental Rating

3

Taking everything into account, HOOK scores 3 out of 10 in our fundamental rating. HOOK was compared to 563 industry peers in the Biotechnology industry. The financial health of HOOK is average, but there are quite some concerns on its profitability. While showing a medium growth rate, HOOK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HOOK had negative earnings in the past year.
HOOK had a negative operating cash flow in the past year.
HOOK had negative earnings in each of the past 5 years.
In the past 5 years HOOK always reported negative operating cash flow.
HOOK Yearly Net Income VS EBIT VS OCF VS FCFHOOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

HOOK has a Return On Assets (-52.70%) which is comparable to the rest of the industry.
HOOK has a Return On Equity (-84.94%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -52.7%
ROE -84.94%
ROIC N/A
ROA(3y)-47.11%
ROA(5y)-44.97%
ROE(3y)-79.69%
ROE(5y)-70.35%
ROIC(3y)N/A
ROIC(5y)N/A
HOOK Yearly ROA, ROE, ROICHOOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HOOK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HOOK Yearly Profit, Operating, Gross MarginsHOOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

More info and screens

6

2. Health

2.1 Basic Checks

HOOK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HOOK has about the same amount of shares outstanding.
HOOK has less shares outstanding than it did 5 years ago.
There is no outstanding debt for HOOK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HOOK Yearly Shares OutstandingHOOK Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
HOOK Yearly Total Debt VS Total AssetsHOOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -7.14, we must say that HOOK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.14, HOOK is doing worse than 68.03% of the companies in the same industry.
HOOK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.14
ROIC/WACCN/A
WACC9.91%
HOOK Yearly LT Debt VS Equity VS FCFHOOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.27 indicates that HOOK has no problem at all paying its short term obligations.
HOOK's Current ratio of 3.27 is on the low side compared to the rest of the industry. HOOK is outperformed by 62.70% of its industry peers.
HOOK has a Quick Ratio of 3.27. This indicates that HOOK is financially healthy and has no problem in meeting its short term obligations.
HOOK's Quick ratio of 3.27 is on the low side compared to the rest of the industry. HOOK is outperformed by 60.04% of its industry peers.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27
HOOK Yearly Current Assets VS Current LiabilitesHOOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.11% over the past year.
The Revenue has grown by 118.24% in the past year. This is a very strong growth!
Measured over the past years, HOOK shows a very strong growth in Revenue. The Revenue has been growing by 29.77% on average per year.
EPS 1Y (TTM)60.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.55%
Revenue 1Y (TTM)118.24%
Revenue growth 3Y33.55%
Revenue growth 5Y29.77%
Sales Q2Q%-81.72%

3.2 Future

HOOK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.13% yearly.
Based on estimates for the next years, HOOK will show a very negative growth in Revenue. The Revenue will decrease by -16.44% on average per year.
EPS Next Y26.59%
EPS Next 2Y23.54%
EPS Next 3Y17.32%
EPS Next 5Y8.13%
Revenue Next Year-60.79%
Revenue Next 2Y-85.73%
Revenue Next 3Y-41.16%
Revenue Next 5Y-16.44%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HOOK Yearly Revenue VS EstimatesHOOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10M 20M 30M 40M 50M
HOOK Yearly EPS VS EstimatesHOOK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HOOK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HOOK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HOOK Price Earnings VS Forward Price EarningsHOOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HOOK Per share dataHOOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 -6

4.3 Compensation for Growth

HOOK's earnings are expected to grow with 17.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.54%
EPS Next 3Y17.32%

More info and screens

0

5. Dividend

5.1 Amount

HOOK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HOOKIPA PHARMA INC

NASDAQ:HOOK (5/5/2025, 8:16:24 PM)

After market: 1.26 -0.02 (-1.56%)

1.28

-0.06 (-4.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-28 2025-02-28/dmh
Earnings (Next)05-07 2025-05-07
Inst Owners59.21%
Inst Owner Change0%
Ins Owners1.93%
Ins Owner Change0%
Market Cap15.44M
Analysts77.78
Price Target25.25 (1872.66%)
Short Float %0.14%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-112.83%
Min EPS beat(2)-241.28%
Max EPS beat(2)15.62%
EPS beat(4)2
Avg EPS beat(4)-9.86%
Min EPS beat(4)-241.28%
Max EPS beat(4)205.21%
EPS beat(8)3
Avg EPS beat(8)-6.37%
EPS beat(12)6
Avg EPS beat(12)-3.46%
EPS beat(16)8
Avg EPS beat(16)-3.74%
Revenue beat(2)0
Avg Revenue beat(2)-52.91%
Min Revenue beat(2)-79.59%
Max Revenue beat(2)-26.23%
Revenue beat(4)1
Avg Revenue beat(4)248.37%
Min Revenue beat(4)-82.17%
Max Revenue beat(4)1181.48%
Revenue beat(8)3
Avg Revenue beat(8)129.5%
Revenue beat(12)4
Avg Revenue beat(12)75.44%
Revenue beat(16)7
Avg Revenue beat(16)56.62%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-477.78%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB 0.3
EV/EBITDA N/A
EPS(TTM)-3.51
EYN/A
EPS(NY)-2.58
Fwd EYN/A
FCF(TTM)-6.4
FCFYN/A
OCF(TTM)-6.38
OCFYN/A
SpS3.64
BVpS4.25
TBVpS4.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.7%
ROE -84.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.11%
ROA(5y)-44.97%
ROE(3y)-79.69%
ROE(5y)-70.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.05%
Cap/Sales 0.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z -7.14
F-Score3
WACC9.91%
ROIC/WACCN/A
Cap/Depr(3y)87.86%
Cap/Depr(5y)118.36%
Cap/Sales(3y)18.78%
Cap/Sales(5y)27.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.55%
EPS Next Y26.59%
EPS Next 2Y23.54%
EPS Next 3Y17.32%
EPS Next 5Y8.13%
Revenue 1Y (TTM)118.24%
Revenue growth 3Y33.55%
Revenue growth 5Y29.77%
Sales Q2Q%-81.72%
Revenue Next Year-60.79%
Revenue Next 2Y-85.73%
Revenue Next 3Y-41.16%
Revenue Next 5Y-16.44%
EBIT growth 1Y47.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-105.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.82%
OCF growth 3YN/A
OCF growth 5YN/A